Keywords: Digestive, Treatment Response, rectal cancer, mrTRG
Motivation: Rectal cancer response assessment criteria utilize T2-weighted and diffusion-weighted images. High-resolution dynamic and delayed post-contrast images with gadolinium-based contrast are not used.
Goal(s): Assess the value of gadolinium washout on delayed post-contrast T1 weighted images to predict residual cancer.
Approach: In 34 patients with at least T2N0 rectal cancer pre-treatment, we compared the gadolinium washout on T1-weighted images during neoadjuvant therapy with the 1-year outcome after surgery or surveillance.
Results: The presence of gadolinium washout on delayed post-contrast images obtained 4-12 weeks after radiation and 4-12 weeks after completion of total neoadjuvant therapy has a 100% positive predictive value for residual rectal cancer.
Impact: Gadolinium washout may be useful in conjunction with T2-weighted and diffusion-weighted images for accurate assessment of rectal cancer treatment response.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords